Healthcare -
Biotechnology - NASDAQ - US
$ 128.0
0.361 %
$ 6.24 B
Market Cap
-21.33
P/E
AXSM - LONG-TERM DEBT
Long-term Debt AXSM - Axsome Therapeutics, Inc.
190 M
LAST VALUE
41.86%
2 YEAR CAGR
61.38%
5 YEAR CAGR
45.56%
10 YEAR CAGR